Wyeth
Five Giralda Farms
Madison,
NJ 07940
United States - Map
Phone: 973-660-5000
Fax: 973-660-5771
Web Site: http://www.wyeth.com
| Wyeth operates as a research-based pharmaceutical and healthcare company in the United States, the United Kingdom, and internationally. Its Pharmaceuticals segment develops, manufactures, distributes, and sells various products, including neuroscience therapies, vaccines, musculoskeletal therapies, nutritional products, gastroenterology drugs, anti-infectives, oncology therapies, hemophilia treatments, immunological products, and womens healthcare products. This segment offers its products to wholesalers, pharmacies, hospitals, governments, physicians, retailers, and other human healthcare institutions. The companys Consumer Healthcare segment develops, manufactures, distributes, and sells over-the-counter healthcare products comprising analgesics and heat wraps, cough/cold/allergy remedies, nutritional supplements, and hemorrhoidal care and personal care products. This segment sells these products to wholesalers and retailers. Its Animal Health segment develops, manufactures, distributes, and sells various biological and pharmaceutical products for animals, which include vaccines, pharmaceuticals, internal and external parasite control products, and growth implants. This segment markets its products to wholesalers, veterinarians, and other animal healthcare providers. Wyeths product pipeline also includes two Phase III clinical programs in oncology that consist of neratinib (HKI-272), which is under development for the treatment of women with advanced HER-2-positive breast cancer; and bosutinib (SKI-606), a targeted kinase inhibitor under development for the treatment of chronic myelogenous leukemia. It has collaboration agreements with Amgen, Inc; Takeda Pharmaceutical Company Limited; Nycomed; Johnson & Johnson; Medtronic Sofamor Danek, Inc.; Trubion; and Elan Corporation, plc. The company was founded in 1926 and is headquartered in Madison, New Jersey. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Bernard Poussot , 57
Chairman, Chief Exec. Officer, Pres, Head of Consumer Healthcare, Head of Fort Dodge Animal Health Divisions, Chairman of Operations Committee, Chairman of Management Committee, Chairman of Exec. Committee, Chairman of Law/Regulatory Review Committee and Chairman of HR, Benefits & Compensation Committee |
$
4.20M |
$
3.01M | Mr. Gregory Norden , 51
Chief Financial Officer, Principal Accounting Officer, Sr. VP, Member of Management Committee, Member of Law/Regulatory Review Committee, Member of HR, Benefits & Compensation Committee, Member of Law/Regulatory Review Committee and Member of Operations Committee |
$
1.85M |
$
259.00K | Mr. Joseph M. Mahady , 55
Sr. VP, Member of Management Committee, Member of Law/Regulatory Review Committee, Member of HR, Benefits & Compensation Committee, Member of Law/Regulatory Review Committee, Member of Operations Committee and Pres of Wyeth Pharmaceuticals |
$
2.27M |
$
2.12M | Dr. Mikael Dohlsten M.D., Ph.D., 50
Sr. VP, Member of Management Committee, Member of Law/Regulatory Review Committee, Member of HR, Benefits and Compensation Committee, Member of Law/Regulatory Review Committee, Member of Operations Committee and Pres of Wyeth Research |
$
1.16M | N/A | Mr. Lawrence V. Stein , 58
Sr. VP, Gen. Counsel, Member of Management Committee, Member of Law/Regulatory Review Committee, Member of HR, Benefits & Compensation Committee, Member of Law/Regulatory Review Committee and Member of Operations Committee |
$
1.70M | N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.45% Nasdaq 
0.20%
Profile
